Roswell Park Cancer Institute

This early safety study tested whether a special light-activated drug (photodynamic therapy) given during surgery could help the body's immune system fight advanced lung cancer more effectively when combined with immunotherapy. The trial enrolled 5 patients with non-small cell lu…

This early-stage trial aimed to see if adding a new oral drug (decitabine/cedazuridine) to a standard prostate cancer drug (enzalutamide) was safe and could help overcome treatment resistance. It involved 8 men with advanced prostate cancer that had spread and stopped responding …

This early-stage study tested whether two immune-stimulating drugs (rintatolimod and interferon) could help cancer patients fight off COVID-19 infections. The trial aimed to find safe doses and see if the treatment reduced the amount of virus in patients. It was designed for adul…

This study tested a combination of treatments for patients with advanced melanoma that had stopped responding to standard immunotherapy. The approach involved giving patients a personalized vaccine made from their own immune cells, plus three drugs designed to help those cells fi…

This study aimed to understand how different vape flavors and types of nicotine (lab-made vs. tobacco-derived) affect how people puff on e-cigarettes. Researchers measured puffing patterns in 21 daily vapers to learn how product design influences use and appeal. The goal was to g…

This study aimed to understand how people identify and describe the flavors and smells of e-liquids used in vaping. Researchers compared the abilities of everyday vapers and non-users to detect specific flavors and their intensity. The goal was to gather basic information about s…